April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Lymphocytic microparticles modulate macrophages function in experimental choroidal neovascularization
Author Affiliations & Notes
  • Houda Tahiri
    Pharmacology, Université de Montréal/ Ste-Justine Hospital Research Center, Montreal, QC, Canada
  • Samy Omri
    Ophtalmology, Université de Montréal/ Maisonneuve-Rosemont Hospital Research Center, Montreal, QC, Canada
  • Chun Yang
    Pharmacology, Université de Montréal/ Ste-Justine Hospital Research Center, Montreal, QC, Canada
  • Francois Duhamel
    Pharmacology, Université de Montréal/ Ste-Justine Hospital Research Center, Montreal, QC, Canada
  • Sylvain Chemtob
    Pharmacology, Université de Montréal/ Ste-Justine Hospital Research Center, Montreal, QC, Canada
    Ophtalmology, Université de Montréal/ Maisonneuve-Rosemont Hospital Research Center, Montreal, QC, Canada
  • Pierre Hardy
    Pharmacology, Université de Montréal/ Ste-Justine Hospital Research Center, Montreal, QC, Canada
  • Footnotes
    Commercial Relationships Houda Tahiri, None; Samy Omri, None; Chun Yang, None; Francois Duhamel, None; Sylvain Chemtob, None; Pierre Hardy, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4942. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Houda Tahiri, Samy Omri, Chun Yang, Francois Duhamel, Sylvain Chemtob, Pierre Hardy; Lymphocytic microparticles modulate macrophages function in experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4942.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Pathological choroidal neovascularization (CNV) is the major cause of severe vision loss in patients with age-related macular degeneration (AMD). Inflammation is a key component in AMD, and macrophages play an important role in CNV generation. We have demonstrated that human T-lymphocyte-derived microparticles (LMPs) significantly inhibit angiogenesis in several models of ocular neovascularization. In this study, we investigated whether LMPs modulate angiogenic microenvironment by altering macrophages activities.

Methods: LMPs were produced from apoptotic human T lymphocytes after treated with actinomycin D. The effects of LMPs on cell viability and cell migration were studied in apoptosis assay and migration assay respectively. Gene expression in macrophages was evaluated using quantitative RT-PCR. The expression of IL-10 and IL-12 in macrophages (RAW264.7) were determined using FACS analysis. Cell growth of human retinal microvascular endothelial cells was assessed after cells were co-cultured with LMPs pre-treated macrophages. A laser-induced CNV model was used to determine the in vivo antiangiogenic effects of LMPs. CNV was analyzed with computer-assisted semi-quantitative assay using fluorescently labelled choroidal flat-mounts. Immunohistostaining was performed to reveal the infiltration of macrophages in CNV areas.

Results: LMPs dose-dependently inhibited macrophages cell growth without altering cell death. In addition, LMPs dramatically abrogated VEGF-induced macrophages migration. LMPs-pretreated macrophages exhibited strong inhibitory effect on endothelial cell growth and this effect was associated with the increased expression of IL-12, CD36 and HIF-1α. In vivo, intravitreal injection of LMPs significantly suppressed laser-induced CNV and reduced macrophages infiltration at the lesion sites.

Conclusions: These results suggest that LMPs are potent antiangiogenic therapeutic agent. In addition to the direct effects on endothelial cells, LMPs may interfere the proangiogenic environment through modulation of macrophages function during pathophysiological conditions.

Keywords: 412 age-related macular degeneration • 453 choroid: neovascularization • 609 neovascularization  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×